Ligand validation:3OE6

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 3OE6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OE6_OLC_A_1600	51%	68%	0.132	0.956	0.54	0.68	-	-	1	0	60%	0.6
3OE6_OLC_A_1601	30%	70%	0.183	0.917	0.52	0.63	-	-	0	0	60%	0.6
3OE6_OLC_A_1602	26%	68%	0.204	0.908	0.5	0.73	-	-	0	0	64%	0.64
3ODU_OLC_B_1601	26%	69%	0.202	0.916	0.55	0.65	-	-	0	0	60%	0.6
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.